242 related articles for article (PubMed ID: 21146613)
1. Production of biologically active complement factor H in therapeutically useful quantities.
Schmidt CQ; Slingsby FC; Richards A; Barlow PN
Protein Expr Purif; 2011 Apr; 76(2):254-63. PubMed ID: 21146613
[TBL] [Abstract][Full Text] [Related]
2. Production of biologically active recombinant human factor H in Physcomitrella.
Büttner-Mainik A; Parsons J; Jérôme H; Hartmann A; Lamer S; Schaaf A; Schlosser A; Zipfel PF; Reski R; Decker EL
Plant Biotechnol J; 2011 Apr; 9(3):373-83. PubMed ID: 20723134
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional characterization of the product of disease-related factor H gene conversion.
Herbert AP; Kavanagh D; Johansson C; Morgan HP; Blaum BS; Hannan JP; Barlow PN; Uhrín D
Biochemistry; 2012 Mar; 51(9):1874-84. PubMed ID: 22320225
[TBL] [Abstract][Full Text] [Related]
4. The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity.
Tortajada A; Montes T; Martínez-Barricarte R; Morgan BP; Harris CL; de Córdoba SR
Hum Mol Genet; 2009 Sep; 18(18):3452-61. PubMed ID: 19549636
[TBL] [Abstract][Full Text] [Related]
5. Disease-associated N-terminal complement factor H mutations perturb cofactor and decay-accelerating activities.
Pechtl IC; Kavanagh D; McIntosh N; Harris CL; Barlow PN
J Biol Chem; 2011 Apr; 286(13):11082-90. PubMed ID: 21270465
[TBL] [Abstract][Full Text] [Related]
6. Murine Factor H Co-Produced in Yeast With Protein Disulfide Isomerase Ameliorated C3 Dysregulation in Factor H-Deficient Mice.
Kerr H; Herbert AP; Makou E; Abramczyk D; Malik TH; Lomax-Browne H; Yang Y; Pappworth IY; Denton H; Richards A; Marchbank KJ; Pickering MC; Barlow PN
Front Immunol; 2021; 12():681098. PubMed ID: 34054871
[TBL] [Abstract][Full Text] [Related]
7. An Evaluation of the Complement-Regulating Activities of Human Complement Factor H (FH) Variants Associated With Age-Related Macular Degeneration.
Biggs RM; Makou E; Lauder S; Herbert AP; Barlow PN; Katti SK
Invest Ophthalmol Vis Sci; 2022 Nov; 63(12):30. PubMed ID: 36445700
[TBL] [Abstract][Full Text] [Related]
8. Two distinct conformations of factor H regulate discrete complement-binding functions in the fluid phase and at cell surfaces.
Osborne AJ; Nan R; Miller A; Bhatt JS; Gor J; Perkins SJ
J Biol Chem; 2018 Nov; 293(44):17166-17187. PubMed ID: 30217822
[TBL] [Abstract][Full Text] [Related]
9. Comparison of surface recognition and C3b binding properties of mouse and human complement factor H.
Cheng ZZ; Hellwage J; Seeberger H; Zipfel PF; Meri S; Jokiranta TS
Mol Immunol; 2006 Mar; 43(7):972-9. PubMed ID: 16023208
[TBL] [Abstract][Full Text] [Related]
10. Deregulation of Factor H by Factor H-Related Protein 1 Depends on Sialylation of Host Surfaces.
Dopler A; Stibitzky S; Hevey R; Mannes M; Guariento M; Höchsmann B; Schrezenmeier H; Ricklin D; Schmidt CQ
Front Immunol; 2021; 12():615748. PubMed ID: 33732239
[TBL] [Abstract][Full Text] [Related]
11. Recombinant generation of two fragments of the rat complement inhibitory factor H [FH(SCR1-7) and FH(SCR1-4)] and their structural and functional characterization in comparison to FH isolated from rat serum.
Demberg T; Heine I; Götze O; Altermann WW; Seliger B; Schlaf G
Histol Histopathol; 2006 Jan; 21(1):93-102. PubMed ID: 16267790
[TBL] [Abstract][Full Text] [Related]
12. Functional Characterization of Rare Genetic Variants in the N-Terminus of Complement Factor H in aHUS, C3G, and AMD.
Wong EKS; Hallam TM; Brocklebank V; Walsh PR; Smith-Jackson K; Shuttleworth VG; Cox TE; Anderson HE; Barlow PN; Marchbank KJ; Harris CL; Kavanagh D
Front Immunol; 2020; 11():602284. PubMed ID: 33519811
[TBL] [Abstract][Full Text] [Related]
13. Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome.
Hyvärinen S; Meri S; Jokiranta TS
Blood; 2016 Jun; 127(22):2701-10. PubMed ID: 27006390
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the Effect of a Potentiating Anti-Factor H Antibody on Atypical Hemolytic Uremic Syndrome-Associated Factor H Variants.
Dekkers G; Brouwer MC; Jeremiasse J; Kamp A; Biggs RM; van Mierlo G; Lauder S; Katti S; Kuijpers TW; Rispens T; Jongerius I
J Immunol; 2020 Oct; 205(7):1778-1786. PubMed ID: 32848031
[TBL] [Abstract][Full Text] [Related]
15. The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.
Ferreira VP; Herbert AP; Cortés C; McKee KA; Blaum BS; Esswein ST; Uhrín D; Barlow PN; Pangburn MK; Kavanagh D
J Immunol; 2009 Jun; 182(11):7009-18. PubMed ID: 19454698
[TBL] [Abstract][Full Text] [Related]
16. A novel method for real-time analysis of the complement C3b:FH:FI complex reveals dominant negative
Hallam TM; Cox TE; Smith-Jackson K; Brocklebank V; Baral AJ; Tzoumas N; Steel DH; Wong EKS; Shuttleworth VG; Lotery AJ; Harris CL; Marchbank KJ; Kavanagh D
Front Immunol; 2022; 13():1028760. PubMed ID: 36643920
[TBL] [Abstract][Full Text] [Related]
17. Disease-linked mutations in factor H reveal pivotal role of cofactor activity in self-surface-selective regulation of complement activation.
Kerr H; Wong E; Makou E; Yang Y; Marchbank K; Kavanagh D; Richards A; Herbert AP; Barlow PN
J Biol Chem; 2017 Aug; 292(32):13345-13360. PubMed ID: 28637873
[TBL] [Abstract][Full Text] [Related]
18. Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein.
McRae JL; Duthy TG; Griggs KM; Ormsby RJ; Cowan PJ; Cromer BA; McKinstry WJ; Parker MW; Murphy BF; Gordon DL
J Immunol; 2005 May; 174(10):6250-6. PubMed ID: 15879123
[TBL] [Abstract][Full Text] [Related]
19. The Scl1 protein of M6-type group A Streptococcus binds the human complement regulatory protein, factor H, and inhibits the alternative pathway of complement.
Caswell CC; Han R; Hovis KM; Ciborowski P; Keene DR; Marconi RT; Lukomski S
Mol Microbiol; 2008 Feb; 67(3):584-96. PubMed ID: 18093091
[TBL] [Abstract][Full Text] [Related]
20. An engineered construct combining complement regulatory and surface-recognition domains represents a minimal-size functional factor H.
Hebecker M; Alba-Domínguez M; Roumenina LT; Reuter S; Hyvärinen S; Dragon-Durey MA; Jokiranta TS; Sánchez-Corral P; Józsi M
J Immunol; 2013 Jul; 191(2):912-21. PubMed ID: 23772024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
